Zefiro Methane Corp. secured three federally funded projects worth about $1.9 million to plug 12 orphaned oil and gas wells in Ohio and Pennsylvania. The contracts include two Ohio projects totaling $1.47 million and one Pennsylvania project expected to generate at least $435,000 in revenue. Zefiro was the sole bidder on two projects and commands above-market rates, highlighting its strong market reputation. Work is planned to start in December 2026 or January 2027, with flexible scheduling to optimize crew utilization year-round.
Zefiro Methane Corp.'s recent federal contracts for well plugging projects provide context for energy sector activity. For readers following the energy sector, here is Pluang's market snapshot as of Sep 15, 2026 13:21 WIB: out of 30 priced US energy stocks, 21 rose and 6 fell today. Notable prices include Occidental Petroleum Corporation (OXY) at USD 62.28 with a 0.81% increase, Williams Companies Inc (WMB) at USD 72.53 also up 0.81%, and Diamondback Energy Inc (FANG) at USD 206.62 with a 0.80% rise.
In Q3 2026, websites on Cloudflare's network blocked 13.47% of AI crawler requests, more than double the 5.98% blocked a year earlier. This rise in access denial affects how brands appear in AI-generated answers from platforms like ChatGPT, Gemini, a...
JPMorgan Asset Management (Canada) announced the final cash distributions for September 2026 for three of its ETFs traded on the Toronto Stock Exchange. Unitholders of record on October 19, 2026, will receive payments on October 23, 2026. The ETFs an...
Stillwater Critical Minerals Corp. has upgraded to the OTCQX Best Market from the OTCQB Venture Market, beginning trading under the symbol "PGEZF." This move enhances the company's visibility, liquidity, and accessibility to U.S. investors as it adva...
WasabiCard, a stablecoin-based global payment provider, engaged in key partnership discussions at TOKEN2049 Singapore 2026, focusing on white-label card issuing, global payouts, and embedded payments. The company highlighted growing demand in APAC fo...
The global next generation antibody therapeutics market is projected to increase from $5.45 billion in 2026 to $5.76 billion by 2035, growing at a CAGR of 1%. Growth is fueled by advances in biotechnology, rising demand for targeted therapies, and in...
